Bausch Health Companies (BHC) Capital Expenditures Growth (3y) (2012 - 2026)
Bausch Health Companies (BHC) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 28.56% |
| 10 | Bausch Health Companies | 1.68 Bn | 365.34 Mn | 2.52 Bn | 32.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.37% |
| Dec 31, 2025 | 11.71% |
| Sep 30, 2025 | 19.00% |
| Jun 30, 2025 | 23.94% |
| Mar 31, 2025 | 35.72% |
| Dec 31, 2024 | 10.77% |
| Sep 30, 2024 | 4.07% |
| Jun 30, 2024 | 7.95% |
| Mar 31, 2024 | 7.50% |
| Dec 31, 2023 | 7.00% |
| Sep 30, 2023 | -19.66% |
| Jun 30, 2023 | -25.97% |
| Mar 31, 2023 | -13.25% |
| Dec 31, 2022 | -5.42% |
| Sep 30, 2022 | -13.35% |
| Jun 30, 2022 | -5.69% |
| Mar 31, 2022 | -0.71% |
| Dec 31, 2021 | 7.95% |
| Sep 30, 2021 | 25.33% |
| Jun 30, 2021 | 27.38% |